MedPath

第一三共制药(上海)有限公司

Ownership
-
Established
1999-11-18
Employees
-
Market Cap
-
Website
www.daiichisankyo.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

12

NMPA:12

Drug Approvals

复方甲氧那明胶囊

Product Name
阿斯美
Approval Number
国药准字H20033669
Approval Date
Jul 31, 2024
NMPA

Loxoprofen Sodium Tablets

Product Name
乐松
Approval Number
国药准字H20030769
Approval Date
May 24, 2024
NMPA

Olmesartan Medoxomil and Amlodipine Besylate Tablets

Product Name
奥美沙坦酯氨氯地平片
Approval Number
国药准字H20180009
Approval Date
Apr 25, 2023
NMPA

Silodosin Capsules

Product Name
优利福
Approval Number
国药准字H20110100
Approval Date
Aug 11, 2021
NMPA

Pravastatin Sodium Tablets

Product Name
美百乐镇
Approval Number
国药准字H20040101
Approval Date
Dec 17, 2019
NMPA

Pravastatin Sodium Tablets

Product Name
美百乐镇
Approval Number
国药准字H20040100
Approval Date
Dec 17, 2019
NMPA

Pravastatin Sodium Tablets

Product Name
美百乐镇
Approval Number
国药准字H20060271
Approval Date
Dec 17, 2019
NMPA

奥美沙坦酯片

Product Name
傲坦
Approval Number
国药准字H20060371
Approval Date
Dec 4, 2019
NMPA

奥美沙坦酯片

Product Name
傲坦
Approval Number
国药准字H20060372
Approval Date
Dec 4, 2019
NMPA

Olmesartan Medoxomil and Hydrochlorothiazide Tablets

Product Name
奥美沙坦酯氢氯噻嗪片
Approval Number
国药准字H20100035
Approval Date
May 13, 2019
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.